Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2017

European Healthtech startup funding raised during H2 2017.

In H2 2017, 153 European Healthtech companies closed 155 funding rounds and raised €1.7B in equity funding (excluding debt and grants), up 100.2% versus H2 2016. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.7B
+100.2% vs H2 2016 · excl. debt & grants
Funding rounds
155
-13.9% vs H2 2016
Companies
153
Top country
Switzerland
Rank among sectors
#3
11.6% of sector funding
Top-10 round share
69.3%
of disclosed capital
Rounds ≥ €100M
1

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2017 — interactive chart.
Data table
FundingRounds
Jul€237M47
Aug€1.1B29
Sep€207M36
Oct€123M25
Nov€123M18

Top countries

by € raised
Healthtech — top countries by capital, H2 2017 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2017
Switzerland€1.1B
France€239M
UK€172M
Israel€110M
Germany€59M
Sweden€44M
Ireland€17M
Finland€15M

Stage mix

by € raised
Healthtech — stage mix, H2 2017 — interactive chart.
Data table
Healthtech — stage mix, H2 2017
Growth/Late€938M
Other€370M
Series A€174M
Series B€131M
Series C€50M
Series D+€48M
Seed€26M
Early VC€4.2M
Grant€1.6M

Exits & M&A

9 Acquisition

9 exits · €112M disclosed.

VisionSenseAcquisitionOct 2017€68M
iSaludAcquisitionSep 2017€30M
VitalsanaAcquisitionOct 2017€14M

Top deals

largest disclosed rounds in H2 2017
CompanyStageDateAmount
Roivant SciencesGrowth/LateAug 2017€938M
NouscomSeries BNov 2017€42M
Ada healthSeries AOct 2017€40M
NightstarSeries CJul 2017€39M
Sophia GeneticsSeries D+Jul 2017€26M
NicOxOtherSep 2017€26M
Natural CyclesSeries BNov 2017€26M
MitrAssistOtherNov 2017€26M
GenSight BiologicsOtherSep 2017€23M
DoctorlinkOtherOct 2017€22M
Push DoctorSeries BAug 2017€22M
IesoOtherSep 2017€20M
Eligo BioscienceSeries ASep 2017€17M
SparingvisionOtherJul 2017€16M
BioserenitySeries AAug 2017€15M

Top investors

most active in H2 2017, by deal count